What CBD Products Are Approved Under Medicare?

Name: Medicare-Approved CBD Products: What Qualifies | Edify
Creator: Edify Wellness Team
Published: 2026-04-11

Written by the Edify Wellness Team

Not every CBD product qualifies under the Medicare Substance Access BEI. CMS set strict standards for what can be furnished through the program. Products must be orally administered, hemp-derived, third-party tested, and within specific THC limits. Inhalable products, topicals used under the BEI, and synthetic cannabinoids don't make the cut.

This page breaks down exactly what qualifies and how Edify's products measure up. For the full program overview, see our complete Medicare CBD guide.

Product Qualification at a Glance

Must be orally administered (gummies, tinctures, capsules)
Must be hemp-derived (not marijuana-derived)
0.3% or less delta-9 THC by dry weight
3mg or less total THC per serving
Must be third-party tested for potency, contaminants, and microbial hazards
No vapes, no smokable products
No synthetic or non-naturally occurring cannabinoids

The CMS Product Requirements in Detail

Oral Administration Only

This is the most important filter. Products must be taken by mouth. Gummies, tinctures, capsules, and softgels all qualify. Anything inhaled, smoked, or vaped is excluded. Transdermal patches and topicals are not covered under the BEI benefit, though they may still be used as complementary products purchased directly.

Hemp-Derived Cannabinoids Only

The cannabinoids in qualifying products must come from hemp plants, not marijuana. Hemp is federally defined as cannabis with 0.3% or less delta-9 THC by dry weight. This distinction matters because hemp is legal under the Farm Bill at the federal level, which is what makes the BEI possible in the first place.

THC Thresholds

Two separate THC limits apply:

Product level: 0.3% or less delta-9 THC by dry weight
Serving level: 3mg or less total THC per serving

Both thresholds must be met. A product can be within the 0.3% limit at the product level but still fail if a serving size delivers more than 3mg of total THC.

Third-Party Testing Requirements

Products must be tested by an independent laboratory (not the manufacturer) for:

Cannabinoid potency (to verify CBD and THC content)
Contaminants (pesticides, heavy metals, residual solvents)
Microbial hazards (bacteria, mold, yeast)

The test results must be documented and available. This is what Certificates of Analysis (COAs) are for. Without a COA from an accredited third-party lab, a product can't be considered compliant.

No Synthetic Cannabinoids

All cannabinoids in qualifying products must be naturally occurring and plant-derived. Lab-created or chemically synthesized cannabinoids (even if structurally similar to natural ones) are excluded.

Why Edify Fits the BEI Rules

Here's a direct comparison of what CMS requires versus what Edify delivers:

BEI Requirement	Edify Compliance
Oral administration only	Yes. Gummies and tinctures (taken by mouth)
Hemp-derived	Yes. Kentucky-grown hemp, Seed-to-Self
0.3% or less delta-9 THC	Yes. Every batch tested and verified
3mg or less total THC per serving	Yes. Lab results confirm compliance
Third-party tested	Yes. Independent lab testing with public COAs
No inhalable products	Correct. Our qualifying products are all oral
No synthetic cannabinoids	Correct. All-natural, plant-based formulations

You can verify this yourself. Every COA for every Edify product is published on our lab results page. No guesswork, no trust-me claims. The numbers are there.

Edify Products That Qualify

The following products meet every CMS requirement for the Substance Access BEI:

__PROTECT_2__

Formulated for nighttime use. Hemp-derived, orally administered, third-party tested. A good option for Medicare patients managing sleep disturbances related to chronic pain or anxiety.

__PROTECT_3__

Built for recovery and pain management. Oral delivery, compliant THC levels, clean ingredients. A strong fit for patients in the Enhancing Oncology Model dealing with pain or treatment side effects.

__PROTECT_4__

A balanced daily wellness gummy. Hemp-derived, within all THC thresholds, third-party tested on every batch.

__PROTECT_5__

Higher CBD potency for patients who need more support. Still within the 3mg total THC per serving limit, verified by lab testing.

__PROTECT_6__

Designed for daytime energy and focus. THCV is a naturally occurring cannabinoid from hemp. Third-party tested and fully compliant.

__PROTECT_7__

For patients who want zero THC. Third-party verified as THC-free. Oral administration via sublingual dosing.

__PROTECT_8__

Full plant profile including minor cannabinoids. Verified to contain 0.3% or less delta-9 THC and under 3mg total THC per serving. Excellent bioavailability.

What Doesn't Qualify (And What You Can Still Buy Directly)

Under the BEI benefit specifically:

Topical products (like our CBD Roll-On Stick) are not covered because they're not orally administered
Vapes, tinctures used as inhalants, and smokable products are excluded
Any product with synthetic cannabinoids is excluded

That said, topical products like a CBD roll-on are still available for direct purchase and may complement your care plan. They just don't fall under the BEI benefit specifically.

About Edify's Quality Standards

Edify is based in Kentucky and grows its own hemp. Our Seed-to-Self process means we control every step from planting to packaging. We work with a USDA-certified organic farm, and our processing facilities are held to the same standards. Learn about where it all begins on our farm and USDA compliance page.

Our nano-enhanced CBD formulations are designed for maximum absorption. More of what you take actually reaches your bloodstream compared to standard oil-in-water emulsions. That matters when you're using CBD to manage real symptoms.

Every product is vegan, plant-based, and free of melatonin, artificial dyes, and synthetic fillers. If you want to see exactly what's in a product before ordering, start with our COA library.

Your cart is currently empty.